Literature DB >> 29155131

Human lung epithelial cell cultures for analysis of inhaled toxicants: Lessons learned and future directions.

Pieter S Hiemstra1, Gwendolynn Grootaers2, Anne M van der Does3, Cyrille A M Krul2, Ingeborg M Kooter2.   

Abstract

The epithelium that covers the conducting airways and alveoli is a primary target for inhaled toxic substances, and therefore a focus in inhalation toxicology. The increasing concern about the use of animal models has stimulated the development of in vitro cell culture models for analysis of the biological effects of inhaled toxicants. However, the validity of the current in vitro models and their acceptance by regulatory authorities as an alternative to animal models is a reason for concern, and requires a critical review. In this review, focused on human lung epithelial cell cultures as a model for inhalation toxicology, we discuss the choice of cells for these models, the cell culture system used, the method of exposure as well as the various read-outs to assess the cellular response. We argue that rapid developments in the 3D culture of primary epithelial cells, the use of induced pluripotent stem cells for generation of lung epithelial cells and the development of organ-on-a-chip technology are among the important developments that will allow significant advances in this field. Furthermore, we discuss the various routes of application of inhaled toxicants by air-liquid interface models as well as the vast array of read-outs that may provide essential information. We conclude that close collaboration between researchers from various disciplines is essential for development of valid methods that are suitable for replacement of animal studies for inhalation toxicology.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Air-liquid interface; Airway; Cell culture; Epithelial cells; Inhalation toxicology; Lung

Mesh:

Substances:

Year:  2017        PMID: 29155131     DOI: 10.1016/j.tiv.2017.11.005

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  37 in total

1.  Co-cultured microfluidic model of the airway optimized for microscopy and micro-optical coherence tomography imaging.

Authors:  Zhongyu Liu; Stephen Mackay; Dylan M Gordon; Justin D Anderson; Dustin W Haithcock; Charles J Garson; Guillermo J Tearney; George M Solomon; Kapil Pant; Balabhaskar Prabhakarpandian; Steven M Rowe; Jennifer S Guimbellot
Journal:  Biomed Opt Express       Date:  2019-09-30       Impact factor: 3.732

2.  Anti-inflammatory actions of aspirin-triggered resolvin D1 (AT-RvD1) in bronchial epithelial cells infected with Cryptococcus neoformans.

Authors:  Bruno Sada Salerno; Aline Beatriz Mahler Pereira; Henrique Ismarsi de Souza; Mario Leon Silva-Vergara; Bruce David Levy; Alexandre Paula Rogerio
Journal:  Inflammopharmacology       Date:  2021-08-17       Impact factor: 4.473

3.  In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities.

Authors:  Arianna Bassan; Vinicius M Alves; Alexander Amberg; Lennart T Anger; Lisa Beilke; Andreas Bender; Autumn Bernal; Mark T D Cronin; Jui-Hua Hsieh; Candice Johnson; Raymond Kemper; Moiz Mumtaz; Louise Neilson; Manuela Pavan; Amy Pointon; Julia Pletz; Patricia Ruiz; Daniel P Russo; Yogesh Sabnis; Reena Sandhu; Markus Schaefer; Lidiya Stavitskaya; David T Szabo; Jean-Pierre Valentin; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2021-09-13

Review 4.  Lung Models to Evaluate Silver Nanoparticles' Toxicity and Their Impact on Human Health.

Authors:  Jesús Gabriel González-Vega; Juan Carlos García-Ramos; Rocio Alejandra Chavez-Santoscoy; Javier Emmanuel Castillo-Quiñones; María Evarista Arellano-Garcia; Yanis Toledano-Magaña
Journal:  Nanomaterials (Basel)       Date:  2022-07-05       Impact factor: 5.719

5.  Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection.

Authors:  Patrick Carius; Justus C Horstmann; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2021

6.  Effects of cigarette smoke extract on bronchial epithelial cells stimulated with Cryptococcus neoformans.

Authors:  Aline Beatriz Mahler Pereira; Jhony Robison Oliveira; Ana Leticia Julio Souza; Leonardo Andrade-Silva; Marcos Vinicius Silva; Paulo Roberto Silva; Mario Leon Silva-Vergara; Alexandre Paula Rogerio
Journal:  Med Microbiol Immunol       Date:  2021-07-06       Impact factor: 3.402

Review 7.  Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics.

Authors:  Arbel Artzy-Schnirman; Sivan Arber Raviv; Ofri Doppelt Flikshtain; Jeny Shklover; Netanel Korin; Adi Gross; Boaz Mizrahi; Avi Schroeder; Josué Sznitman
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 15.470

Review 8.  Bronchial Epithelial Cells on the Front Line to Fight Lung Infection-Causing Aspergillus fumigatus.

Authors:  Jeanne Bigot; Loïc Guillot; Juliette Guitard; Manon Ruffin; Harriet Corvol; Viviane Balloy; Christophe Hennequin
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

9.  Protein profile of well-differentiated versus un-differentiated human bronchial/tracheal epithelial cells.

Authors:  Wen-Kuan Liu; Duo Xu; Yun Xu; Shu-Yan Qiu; Li Zhang; Hong-Kai Wu; Rong Zhou
Journal:  Heliyon       Date:  2020-06-23

10.  The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel.

Authors:  Ilona Gróf; Alexandra Bocsik; András Harazin; Ana Raquel Santa-Maria; Gaszton Vizsnyiczai; Lilla Barna; Lóránd Kiss; Gabriella Fűr; Zoltán Rakonczay; Rita Ambrus; Piroska Szabó-Révész; Fabien Gosselet; Pongsiri Jaikumpun; Hajnalka Szabó; Ákos Zsembery; Mária A Deli
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.